Skip to content

KISSeS

Pilot study on Ketosis Impact on Signs and Symptoms of Schizophrenia and Bipolar Disorders - KISSeS

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON56800
Enrollment
28
Registered
2023-12-19
Start date
2024-12-09
Completion date
Unknown
Last updated
2026-06-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

schizophrenia spectrum disorders schizophrenia

Interventions

Oral intake of nutritional drink (25g dGK versus isocaloric carbohydrate drink). Patients (n=28) will follow a crossover trial, and be randomised in a double-blind fashion to either intervention first

Sponsors

Amsterdam UMC
Lead Sponsor

Eligibility

Age
18 Years to 64 Years

Inclusion criteria

Inclusion criteria: Patients diagnosed with schizophrenia or bipolar disorder who are in at least partial remission receiving standard care able to give informed consent age 18 - 65 years old

Exclusion criteria

Exclusion criteria: Acute/florid psychosis, acute mania (unremitted) inability to give (informed) consent age < 18 or > 65 years old. liver function disorder kidney function disorder cardiovascular disease ketone body metabolism disorder diabetes pregnancy or lactating

Design outcomes

Primary

MeasureTime frame
The primary outcome measure is percent change between intervention (dGK ingestion) vs control (isocaloric gold standard drink) in PPI.  

Secondary

MeasureTime frame
Secondary outcome measures include percent change between intervention and control drink: in basal EEG, P300 ERP, cognitive test scores; patient-experienced improvement in energy level, mood, ability to focus (visual analogue scale); metabolic and immune parameters (blood, sweat and saliva biomarkers; indirect calorimetry).

Countries

Netherlands

Contacts

Public ContactK Huizer

Amsterdam UMC

k.huizer@parnassiagroep.nl0614606175

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP) · Data processed: Jun 11, 2026